---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-288513"
form_type: "8-K"
ticker: null
cik: "0001426332"
company_name: "NGM BIOPHARMACEUTICALS INC"
filed_at: "2023-12-04T23:59:59+00:00"
generated_at: "2026-06-07T18:40:30.555492+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# NGM Biopharmaceuticals receives Nasdaq bid price deficiency notice; stock below $1.00 for 30 days

## Summary
- Received Nasdaq notice on Dec 1, 2023; bid price below $1.00 for 30 consecutive business days.
- Has until May 29, 2024 (180 days) to regain compliance by closing at $1.00+ for 10 consecutive days.
- May transfer to Nasdaq Capital Market for an additional 180-day compliance period if needed.
- Company will monitor and consider options, including a potential reverse stock split, to cure deficiency.

## SEC filing metadata
- accession: 0001193125-23-288513
- form_type: 8-K
- cik: 0001426332
- company_name: NGM BIOPHARMACEUTICALS INC
- filed_at: 2023-12-04T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1426332/000119312523288513/0001193125-23-288513-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1426332/000119312523288513/d618000d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-288513
- JSON: https://secwatch.observer/filing/0001193125-23-288513.json
- Plain text: https://secwatch.observer/filing/0001193125-23-288513.txt

## Key facts
- Listing & Compliance Notices
  NGM BIOPHARMACEUTICALS INC received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5450(a)(1), 5810(c)(3)(A)
  source text: December 1, 2023, NGM Biopharmaceuticals, Inc., a Delaware corporation (the “Company”), received a letter from the Listing Qualifications Staff (the “Nasdaq Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that for the last 30 consecutive business days, the bid price of the Company’s common stock had closed below $1.00 per share, the minimum closing bid price required by the continued listing requirements of Nasdaq Listing Rule 5450(a)(1). The notification received has no immediate effect on the listing of the Company’s common stock on The Nasdaq Global Select Market. In
  evidence_url: https://www.sec.gov/Archives/edgar/data/1426332/000119312523288513/0001193125-23-288513-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.